Lim, S. K. (2022). Thiazolidinediones Pretreated Bone Marrow-Derived Mesenchymal Stem Cells As An Anti-Cancer Approach Against Mcf-7 Breast Cancer Cell Line.
Chicago Style (17th ed.) CitationLim, Shern Kwok. Thiazolidinediones Pretreated Bone Marrow-Derived Mesenchymal Stem Cells As An Anti-Cancer Approach Against Mcf-7 Breast Cancer Cell Line. 2022.
MLA (9th ed.) CitationLim, Shern Kwok. Thiazolidinediones Pretreated Bone Marrow-Derived Mesenchymal Stem Cells As An Anti-Cancer Approach Against Mcf-7 Breast Cancer Cell Line. 2022.
Warning: These citations may not always be 100% accurate.